Urine test to help women stick with HIV prevention pills in Kenya
Part of Infections clinical trials.
This study tests a quick urine test to see if it helps women in Kenya who struggle to take their daily HIV prevention pills (PrEP) stay on track. If you're already taking PrEP but have had trouble taking it every day, this trial might help you and your doctor find ways to improve your routine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You do not have HIV.
- You have been taking daily PrEP pills for the past month and had a negative urine test one month after starting.
- You are currently going to or are willing to go to one of the study clinics for PrEP refills.
- You want to keep taking PrEP even though you have had trouble taking it consistently.
- You do not have a known HIV-positive partner.
- You live in Kiambu County and plan to stay there for the next year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
This study tests whether a program called 'PrEP My Way' can help young women in Kenya stick with taking PrEP pills to prevent HIV. It's designed for women ages 16–24 who are just starting PrEP in Kisumu County.
This trial tests whether a simple urine test can help people living with HIV who have not yet achieved viral suppression. The test is done right at the clinic to quickly check if their HIV medication is being taken correctly, so their doctor can offer extra support.
This trial tests a “one-stop” support pathway meant to make it easier for PrEP clinics in Kenya to deliver PrEP care. It involves interviews with people using PrEP services and with healthcare and policy leaders who help run or guide PrEP delivery.
This trial looks at how well a daily HIV-prevention pill (F/TAF) works in people who use drugs. The goal is to understand real-world effectiveness and help support people in staying HIV-negative.
This study tests a program to help adolescent girls and young women at high risk of HIV take PrEP consistently. It aims to improve access and adherence to PrEP, a daily pill that prevents HIV.
Hear when a new PrEP Adherence Monitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.